Use of botulinum toxin type A in management of adult spasticity--a European consensus statement.
Ward
Anthony B
AB
Department of Rehabilitation Medicine, North Staffordshire Hospital, Stoke-on Trent, UK.
Aguilar
Miguel
M
De Beyl
Zegers
Z
Gedin
Susanne
S
Kanovsky
Petr
P
Molteni
Franco
F
Wissel
Jörg
J
Yakovleff
Anton
A
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D032921:Consensus; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005060:Europe; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009128:Muscle Spasticity / Q000175:diagnosis / Q000188:drug therapy* / Q000534:rehabilitation; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D019274:Botulinum Toxins, Type A